1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Hires Keith Burba to Expand Energy Investment Banking Practice in Houston

Our Firm

May 28, 2019

Guggenheim Securities Hires Keith Burba to Expand Energy Investment Banking Practice in Houston

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Keith Burba will join the firm as a Senior Managing Director in the Energy Investment Banking group. Mr. Burba will focus on advising oil & gas companies and will commence work at Guggenheim in August.

Mr. Burba has more than 15 years of investment banking experience and will join Guggenheim from Barclays, where he most recently served as a Managing Director and Co-Head of Houston Natural Resources Investment Banking. During his time at Barclays, Mr. Burba focused on upstream and midstream energy companies. Mr. Burba began his investment banking career at Lehman Brothers in 2004.

“Guggenheim is excited for Keith to join the firm,” said Mark Van Lith, Co-CEO of Guggenheim Securities and Head of Investment Banking. “Keith is a well-respected advisor to leading energy companies and will be an important contributor to our rapidly growing Houston investment banking franchise. We look forward to Keith’s continued success on the Guggenheim platform.”

Mr. Burba received his B.B.A. and M.B.A. from the University of Mississippi. He will be based in Guggenheim’s Houston office.


About Guggenheim Securities

Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers services that fall into four broad categories: Advisory, Financing, Sales and Trading, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Chicago, Boston, Atlanta, San Francisco, and Houston. For more information, please contact us at GSinfo@GuggenheimPartners.com or 212.518.9200.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $265 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,400 professionals based in offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.


Media Contact

Ellen Cunningham
Guggenheim Partners
212.518.9578
Ellen.N.Cunningham@GuggenheimPartners.com

 

1Assets under management are as of 3.31.2019 and include consulting services for clients whose assets are valued at approximately $60bn.



November 09, 2020

Guggenheim Securities Hires David Levin to Expand Equity Capital Markets

NEW YORK, NY –  Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that David Levin will join the firm as a Senior Managing Director in Equity Capital Markets, focusing on providing clients with equity and equity-linked financing solutions through the public and alternative equity capital markets.

Read More

October 22, 2020

Guggenheim Securities Hires Joe Niemiec to Expand Middle Market Investment Banking Practice

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Joe Niemiec has joined the firm as a Senior Managing Director to expand its middle market investment banking coverage and to focus on advising companies in the services and industrials sectors.

Read More

October 05, 2020

Debjit Chattopadhyay Joins Guggenheim Securities as Senior Biotech Analyst

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Debjit Chattopadhyay will join the firm in December as a Managing Director and Senior Biotech Analyst as part of the Healthcare Equity Research team. Dr. Chattopadhyay’s research focus will be gene therapy and rare diseases.

Read More



© 2020 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.